ANALYSIS OF POTENTIAL DRUGS INTERACTION ON ANTIHYPERTENSION DRUGS PRESCRIPTION IN COMMUNITY HEALTH CENTER OF SUKMAJAYA DISTRICT IN PERIOD OF JUNE-NOVEMBER 2015

Atika Wahyu Puspitasari; Azizahwati Azizahwati; Ayu Rahmawati Hidayat

doi:10.22159/ajpcr.2017.v10s5.23098

Authors

Atika Wahyu Puspitasari Department of Clinical Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia
Azizahwati Azizahwati Department of Clinical Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia
Ayu Rahmawati Hidayat Department of Clinical Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia

DOI:

https://doi.org/10.22159/ajpcr.2017.v10s5.23098

Keywords:

Antihypertensive, Potential drug interactions, Prescription

Abstract

Objectives: Hypertension is a common disease around the world. Depending on the severity or the presence of other diseases, whether related or unrelated, additional drug therapy may be required to optimize treatment and to reduce the side effects of drugs. The use of drugs in large amounts may increase the risk of drug interactions. The purpose of this research was to evaluate the characteristics of hypertension patients, prescriptions, and potential drug interactions in hypertensive patients in the Sukmajaya Community Health Center from June to November 2015.

Methods: This research used a descriptive analytic method and the data were retrospectively obtained.

Results: The results were based on the analysis of 350 prescriptions of female (67.43%) and male (32.57%) patients, with the highest prevalence of hypertension occurring at the age of â‰¥55 years. Potential drug interactions were analyzed using Micromedex. The most frequent potential interaction resulted from the combined use of captopril and non-steroidal anti-inflammatory drugs. The most frequent mechanism of drug interaction was pharmacokinetics (51.06%). The chi-square test results showed a significant relationship between the number of prescribed drugs and potential interactions at a probability value of 0.0001 and an odds ratio of 5.940 (15.588-2.263).

Conclusions: With respect to interaction mechanism, pharmacokinetic (51.06%) was the most frequent and 61.70% of potential cases involved a moderate interaction risk.

Downloads

Download data is not yet available.

References

Stockley IH. Stockleyâ€™s Drug Interactions. 8th ed. London: The Pharmaceutical Press; 2008.

Syamsudin. Interaksi Obat: Konsep Dasar dan Klinis. Jakarta: Penerbit Universitas Indonesia (UI-Press); 2011.

Rumanda N. Potensi Interaksi Obat Antihipertensi pada Pasien Hipertensi di Puskesmas di Kota Medan. Medan: Fakultas Farmasi Universitas Sumatera Utara; 2015.

Dinas Kesehatan Kota Depok. Profil Kesehatan Kota Depok Tahun 2013. Depok: Dinas Kesehatan Kota Depok; 2013.

Pusat Data dan Informasi Kementerian Kesehatan RI. Info Datin Hipertensi. Jakarta: Pusat Data dan Informasi Kementerian Kesehatan RI; 2014.

Igho Pemu P, Ofili E. Hypertension in women: Part I. J Clin Hypertens (Greenwich) 2008;10(5):406-10.

Lionakis N, Mendrinos D, Sanidas E, Favatas G, Georgopoulou M. Hypertension in the elderly. World J Cardiol 2012;4(5):135-47.

Sumawa PM, Wulllur AC, Yamlean PV. Evaluation on the rationality of the use of anti-hypertensive drugs on hypertension in-patients of Prof. DR. R. D. Kandou Hospital, Manado during January-June 2014. J Ilmiah Farmasi 2015;4(3):2302-493.

Department of Health and Human Services. The Seventh Report of the Joint National Commite on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. United State: Department of Health and Human Services; 2004.

Pascual J. Hypertension control in the elderly with amlodipine. Curr Med Res Opin 2000;16(1):33-6.

Baharudin KP, Suwandi D. Perbandingan Efektivitas dan Efek Samping Obat Antihipertensi Terhadap Penurunan Tekanan Darah Pasien Hipertensi. Sulawesi Selatan: Fakultas Kedokteran Universitas Hasanudin; 2013.

Kristanti P. Effectiveness and Side Effects of Anti-hypertensive Medication Usage in Hypertension Patients at Kalirungkut Public Health Center,Surabaya. Jurnal Ilmiah Mahasiswa Universitas Surabaya 2015;4(2):4.

Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007;63(2):187-95.

Arauz-Pacheco C, Ramirez LC, Rios JM, Raskin P. Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy. Am J Med 1990;89(6):811-3.